How to Start a Telehealth Business: the End-to-end Guide

What a telehealth business actually is

Peel back the branding and a telehealth business is three layers stacked on top of each other: software that runs the patient experience, licensed providers who deliver the care, and — for most profitable models — a pharmacy that fulfills what those providers prescribe. Bolt on a way to acquire patients and a compliant legal structure, and you have a company.

The reason so many first-time founders stall is that they treat one of those layers as "the business" and discover the other two are just as hard. A software person builds a beautiful app and then can't prescribe anything. A clinician has patients and prescribing capacity but no infrastructure to scale. A marketer drives demand to a funnel that has no provider or pharmacy behind it. A telehealth business only works when all three layers exist and connect cleanly.

That framing also explains why the market splits the way it does. Some vendors sell you software only. Some sell providers-as-a-service. Some sell a single medication category. Very few ship all three together — which is the entire reason this build is usually harder and slower than it should be, and where the biggest lever on your timeline lives. This guide walks the decisions in order: what to sell, how to source each layer, how to stay compliant, and whether the economics hold up.

Pick a vertical (don't try to treat everyone)

The single most common mistake is launching a "general telehealth" service. Generalist telehealth competes with well-funded incumbents on price and convenience, and there's no wedge. The businesses that work pick a cash-pay vertical with clear demand, a defined patient, and a recurring-treatment shape.

The strongest verticals right now share three traits: patients pay out of pocket, care is ongoing rather than one-and-done, and the condition is well-suited to remote evaluation. That points to a familiar shortlist:

• Weight loss / GLP-1 — the largest and fastest-growing category; see our dedicated guide on starting a weight loss clinic.
• Men's health — TRT, enclomiphene, sexual wellness, hair loss; strong recurring revenue and clear demand.
• Women's health / HRT — an underserved, high-retention category.
• Longevity, peptides, and wellness — sermorelin, NAD+, glutathione, methylene blue, lab testing; a fast-growing cash-pay audience.

Pick one to start. A focused brand — "the men's hormone clinic," "the metabolic health program" — converts far better than a menu of everything, and you can expand into adjacent categories later on the same infrastructure. Depth first, breadth second.

Build vs. buy vs. white-label

This is the decision that shapes your cost, your timeline, and how much of the company you actually own. There are three paths.

Build it yourself. Custom software, your own credentialed providers, direct pharmacy contracts, a compliance buildout from scratch. You get maximum control and, eventually, the best margins — but you're looking at six-plus figures of investment and many months (often a year) before your first patient, plus the ongoing cost of maintaining infrastructure that isn't your differentiator. This only makes sense at real scale or with a genuinely novel clinical model.

Buy software, assemble the rest. License an EHR / practice-management platform (the OptiMantra, Healthie, Pabau, Tebra tier) and bolt on providers and pharmacy yourself. Cheaper and faster than a full build, but you're still the systems integrator: sourcing prescribing capacity, negotiating a pharmacy relationship, and stitching the seams — each one a BAA and a potential failure point. Software-only vendors give you one layer of the three.

White-label a full platform. Run your brand on top of infrastructure that already includes software, providers, pharmacy, and ready-made programs. You focus on the brand, the patients, and the growth; the plumbing is handled. This is the fastest path from idea to revenue, and for most first-time operators it's the right one.

The reason the white-label / bundled route is compelling isn't just speed — it's that the layers are pre-connected. Heally is specifically the platform that bundles what competitors sell separately: HIPAA software, a 50-state provider network, pharmacy fulfillment, and switch-on treatment programs, with no startup fees and setup under a day. If a fully branded consumer-facing product is your goal, white-label telehealth and a category-specific brand like the GLP-1 weight loss brand are built for that.

Providers and licensure

A telehealth visit is only legal when the provider is licensed in the state where the patient is located at the time of the visit. That one rule governs your entire growth curve. If you want to serve patients nationally, you need prescribing coverage in all the states you operate in — and building that license-by-license is slow and expensive.

Your options mirror the build/buy/white-label choice. Employ your own providers for control and long-run margin. Contract 1099 clinicians for flexibility. Or use a platform's provider network to reach coverage on day one — Heally's board-certified providers can see and prescribe across all 50 states, so you're not gated on credentialing before you can launch nationally. Many operators start on the network and add employed providers in their densest states later.

Two things founders underestimate: credentialing takes months if you do it yourself, and malpractice coverage plus supervision structures (where applicable) are real recurring costs. A network absorbs both. Whatever route you choose, remember the golden rule of the category — the licensed provider makes every eligibility and prescribing decision. Your funnel can't promise a prescription, and your intake can't be a rubber stamp. The state-level nuances (async vs. synchronous visits, exam requirements, controlled-substance considerations) are covered in our prescribing-rules-by-state overview.

Pharmacy and fulfillment

If your model prescribes medication — and most profitable telehealth models do — someone has to fill and ship it. This is the layer software-only platforms leave entirely to you, and it's harder than it looks.

You'll deal with two categories. Branded/commercial products flow through standard pharmacy channels. Compounded medications — the backbone of GLP-1, hormone, and peptide programs — come from licensed compounding pharmacies, split into 503A (patient-specific compounding) and 503B (outsourcing facilities that can produce larger batches). Which you use has real compliance and supply implications, and it's worth understanding before you commit to a category.

Modern patients expect direct-to-patient shipping with proper cold-chain handling for temperature-sensitive drugs — not a pharmacy pickup. Standing up reliable fulfillment means a pharmacy relationship that can scale with you, handle multiple states, and ship dependably. Getting this wrong shows up as stockouts, delays, and churn.

This is a big part of why the bundle matters: with Heally, pharmacy fulfillment for compounded and branded medications is included and pre-connected to the prescribing and software layers, so you're not negotiating and integrating a pharmacy relationship on your own. Be precise in your marketing regardless of source — compounded medications are prepared by licensed pharmacies and are not FDA-approved.

Compliance and HIPAA

Compliance isn't a phase you finish; it's a standing cost of being in healthcare. Three areas will define whether your business is defensible.

Corporate structure. Many states enforce the corporate practice of medicine, restricting non-provider ownership of clinical entities. The standard answer is a friendly professional entity (PC/PLLC) owned by a licensed provider delivering the care, and a management services organization (MSO) you own handling everything non-clinical. Set this up with a healthcare attorney before launch — it's expensive to unwind later.

HIPAA. From your first patient record you're a covered entity: you need a compliant EHR, business associate agreements with every vendor touching patient data, access controls, audit logs, encryption, and a breach-response plan. Consumer tools — generic CRMs, shared inboxes, spreadsheets — don't meet the bar, and cobbling compliant infrastructure together is a project in itself.

Telehealth and prescribing rules. Requirements for establishing a valid provider-patient relationship, whether an async questionnaire suffices or a live visit is required, and the extra rules for controlled substances all vary by state and change over time. You don't need to memorize 50 rulebooks, but you do need providers and counsel who track them.

The practical reason many operators run on a purpose-built platform is that HIPAA-compliant infrastructure, BAAs, and provider oversight come baked in — you inherit compliance scaffolding instead of assembling it and hoping. It doesn't replace your attorney, but it removes whole classes of mistakes.

The technology stack

Functionally, your platform has to do a lot: a HIPAA-compliant EHR and charting, custom intake forms, scheduling, video visits, e-prescribing, recurring/subscription billing, lab ordering, patient messaging, a patient portal or app, and lifecycle marketing. Under the hood you also need identity/auth, payments, analytics, and the audit and security layer HIPAA demands.

You can assemble this from best-of-breed tools, and some scaled operators do — but every integration is a seam, a BAA, and a thing that breaks. For most new businesses, the value of a single platform is that these components are already integrated and compliant, so your engineering effort (if any) goes into your brand and differentiation instead of plumbing.

Weigh the tiers honestly. Software-only EHR platforms are strong at charting and scheduling but hand you the provider and pharmacy problems. Point solutions cover one drug category. A bundled platform covers all three layers. The through-line of this guide is that the layers being pre-connected — software talking to providers talking to pharmacy — is worth more than any single feature, because that's where time and money actually leak. Heally's HIPAA-compliant EHR, scheduling, video, billing, intake, and marketing ship wired to the provider network and pharmacy, which is the whole point.

Go-to-market

Infrastructure doesn't make money; patients do. Your go-to-market has three jobs: get found, convert cleanly, and retain.

Get found. In cash-pay verticals, high-intent search is the workhorse — people already looking for "TRT online," "semaglutide program," or "online HRT." A focused brand, useful content, and a clean site capture that demand. Paid search and social work too, but every ad platform is strict about medical and prescription claims — keep copy compliant and route to a fast intake.

Convert cleanly. The gap between "interested" and "first treatment" is where most revenue dies. A short intake, quick provider turnaround, and transparent pricing convert; friction kills. Because most of your funnel is software, this is largely a design and operations problem you can fix.

Retain. Recurring-treatment verticals live and die on retention. A patient who stays a year is worth several times one who churns in month two, so refill reminders, check-ins, and responsive support aren't nice-to-haves — they're your margin. Lifecycle marketing and patient-support teams that come built into the platform do a lot of this automatically. If you're starting in weight loss specifically, the tactical detail lives in our weight loss clinic guide.

Unit economics

Every telehealth business, regardless of vertical, reduces to the same equation: customer acquisition cost (CAC) versus lifetime value (LTV), with your delivery cost in the middle. If LTV comfortably exceeds CAC plus cost-to-serve, you have a business; if it doesn't, more marketing just loses money faster.

LTV is monthly revenue per patient times retention. Recurring-treatment verticals — GLP-1, hormones, peptides — are attractive precisely because retention can run many months, so a patient acquired once pays back several times. This is why retention tooling is an economic input, not a soft feature.

Cost to serve is medication/pharmacy cost, the provider visit, software, payments, and support. On a bundled platform these are mostly variable — they scale with patients rather than sitting as fixed overhead you have to grow into. That's what lets a program be margin-positive at modest volume instead of requiring scale just to break even.

CAC depends on your vertical and channel discipline, but a clean, compliant funnel with strong conversion keeps it in check.

The reason the startup-cost question looms so large is timing. A from-scratch build spends heavily for months before earning a dollar; that long, negative ramp is what sinks many first attempts. With zero startup fees and sub-day setup, you start generating revenue almost immediately while costs stay variable — which is a large part of why Heally partners report an average $127K annual revenue increase. Model your own CAC, LTV, and margin on a demo, but the structural advantage is consistent: recurring revenue, variable cost, and a short path to payback.